<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Hemorrhagic Brain Metastases in a Patient with Anaplastic Lymphoma Kinase (ALK)-Rearranged Invasive Mucinous Adenocarcinoma of the Lung.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Hemorrhagic Brain Metastases in a Patient with Anaplastic Lymphoma Kinase (ALK)-Rearranged Invasive Mucinous Adenocarcinoma of the Lung." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4724/5796364/5f9153ac3868/amjcaserep-19-99-g002.jpg"/> </div> <div class="text-side"> <h1>Hemorrhagic Brain Metastases in a Patient with Anaplastic Lymphoma Kinase (ALK)-Rearranged Invasive Mucinous Adenocarcinoma of the Lung.</h1> <p>IMA of the lung. (A) Shows neoplastic cells with a goblet and columnar cell morphology with abundant intracytoplasmic mucin and small basally located nuclei. The mucinous tumor cells continued with the non-neoplastic bronchiolar epithelium (black arrow in right image). (B) The neoplastic cells are positive by IHC for CK7, TTF1, napsin A, p63, and negative for p40. (C) Positive ALK FISH break-apart test is shown with split red and green signals, signifying the presence of an ALK rearrangement. (D) The neoplastic cells are positive for vimentin and negative for E-cadherin by IHC. Images in (A), (B), and (D) were acquired at 20× magnification except for center image in panel A and CK7 in panel B that was acquired at 40× magnification with an Olympus BX43 microscope.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29371584/" target="_blank">29371584</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>